“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY

€3.03

SKU: product-article-23750 Category: General

Description
Reviews (0)

Description

P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY

Reviews

There are no reviews yet.

Be the first to review “Article: P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY”

You must be logged in to post a review.

Top

Article: P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Calendar of events

Article: Highlights in gynaecological cancers

Article: Highlights in respiratory oncology